PNG Bita

Calophyllum inophyllum contains bioactive xanthones, coumarins, and chromanones — particularly calophyllolide, inophyllum C, and inophyllum P — that exert antimicrobial effects by disrupting bacterial cell integrity and scavenging free radicals via phenolic-mediated mechanisms. In vitro studies demonstrate hexane bark extract produces a zone of inhibition of 17.96 mm against Staphylococcus aureus, with a minimum inhibitory concentration below 0.098 mg/mL against Bacillus cereus, supporting its traditional role in treating skin infections.

Origin & History

Calophyllum inophyllum is a tropical evergreen tree native to coastal regions spanning East Africa, South and Southeast Asia, the Pacific Islands, and Papua New Guinea, where it is commonly called 'Bita.' It thrives in sandy coastal soils, mangrove margins, and humid tropical lowlands, tolerating salt spray and periodic flooding. The tree is widely cultivated across Pacific Island nations both as a shade tree and for its medicinal oil, seeds, and bark.

Historical & Cultural Context

Calophyllum inophyllum has been used for centuries across Pacific Island cultures, including Papua New Guinea (where it is called 'Bita'), for wound healing, skin infections, eye diseases, and joint pain, with the seed oil (known as tamanu oil in Polynesian traditions) being among the most valued topical remedies in the Pacific ethnobotanical pharmacopoeia. In Traditional Chinese folk medicine, the plant has been documented for treatment of wounds and eye conditions, reflecting broad pan-Asian medicinal recognition. Across coastal Southeast Asia and the Indian subcontinent, the tree's bark, leaves, seeds, and oil have been incorporated into Ayurvedic and traditional Malay medicine for their purported anti-inflammatory and antimicrobial properties. The tree also holds cultural significance as a coastal shade tree planted near villages and temples in Pacific and Indian Ocean communities, symbolizing healing and protection in several indigenous knowledge systems.

Health Benefits

- **Antimicrobial Activity Against Skin Pathogens**: Hexane bark extract of C. inophyllum produced a zone of inhibition of 17.96 mm against Staphylococcus aureus in disc diffusion assays, and 11 of 15 tested extracts showed MIC values below 0.098 mg/mL against Bacillus cereus, directly relevant to skin infection management.
- **Antioxidant Protection**: Methanolic bark extract demonstrated strong DPPH free radical scavenging with an IC₅₀ of 0.004 mg/mL, attributable to high phenolic content (109.16 ± 1.21 mg GAE/g dry weight), which helps neutralize oxidative stress implicated in chronic skin inflammation.
- **Anti-Inflammatory Support**: Calophyllolide and related coumarins modulate inflammatory signaling pathways, reducing pro-inflammatory mediator activity in preclinical models, which may help resolve wound-associated inflammation characteristic of superficial skin infections.
- **Anticancer Cytotoxicity (Preliminary)**: Leaf ethyl acetate extract inhibited lung cancer cells (NCI-H187) by 93.29% with an IC₅₀ of 10.09 ± 1.43 μg/mL, while leaf hexane extract showed 99.11% inhibition at IC₅₀ = 17.45 ± 1.51 μg/mL, indicating potent selective cytotoxicity in cell-based models.
- **Wound Healing Support**: Traditional and in vitro evidence indicates C. inophyllum oil promotes tissue regeneration and reduces microbial load at wound sites, consistent with its documented use in Traditional Chinese folk medicine for treating wounds and eye conditions.
- **Anti-Invasion and Anti-Migration Effects**: At 200 μg/mL, C. inophyllum extract significantly inhibited cancer cell invasion across all tested cancer cell types in vitro, correlated with reduced intracellular reactive oxygen species (ROS) levels, suggesting a role in limiting aggressive cellular behavior.
- **Broad-Spectrum Phytochemical Richness**: Leaf extracts contain alkaloids (11.51%), tannins (7.68%), polyphenols (2.53%), triterpenoids (2.48%), flavonoids (2.37%), and saponins (2.16%), providing a multifunctional phytochemical profile that may act synergistically across antimicrobial and antioxidant pathways.

How It Works

The primary antimicrobial mechanism of C. inophyllum involves its xanthone, coumarin, and chromanone constituents — particularly calophyllolide, inophyllum C, and inophyllum P — which disrupt bacterial membrane integrity and inhibit bacterial enzyme systems, reducing viability of gram-positive pathogens such as S. aureus. Phenolic compounds and tannins contribute by precipitating bacterial proteins and chelating metal ions essential for microbial enzymatic function, reinforcing bacteriostatic and bactericidal effects. The antioxidant mechanism operates through direct free radical scavenging by phenolics, with a strong linear correlation established between total phenolic content and DPPH radical scavenging capacity, while flavonoids contribute hydrogen atom donation and metal ion chelation. In anticancer contexts, extracts modulate intracellular ROS levels below the IC₅₀ threshold to inhibit cancer cell migration and invasion, with downstream effects on gene expression networks governing tumor progression, though specific molecular targets (e.g., kinases or transcription factors) have not yet been fully elucidated in published literature.

Scientific Research

The evidence base for C. inophyllum consists predominantly of in vitro phytochemical characterization and cell-based bioactivity studies, with no human randomized controlled trials identified in the current literature. Antibacterial studies using disc diffusion and MIC assays across 15 extract types have consistently demonstrated activity against S. aureus and B. cereus, while anticancer studies using NCI-H187 (lung), breast cancer, and other cell lines have quantified IC₅₀ values and inhibition percentages. In silico ADME analysis of flower extract compounds (eugenol and caryophyllene oxide) predicts high gastrointestinal absorption and blood-brain barrier permeability with favorable Lipinski Rule compliance, supporting theoretical oral bioavailability, but these findings lack human pharmacokinetic validation. The overall evidence strength is preclinical; while mechanistic plausibility is well-supported, translation to clinical dosing guidance and confirmed human efficacy requires future Phase I/II trials.

Clinical Summary

No human clinical trials have been published for C. inophyllum as a standardized supplement or therapeutic agent for skin infections or other conditions. Available data are restricted to in vitro cell-line experiments and ex vivo extract analyses, which provide biologically plausible but non-transferable efficacy estimates. Cell-based studies report IC₅₀ values ranging from 10.09 to 99.11 μg/mL across cancer cell lines and MIC values below 0.098 mg/mL against bacterial pathogens, outcomes that cannot be directly extrapolated to human dosing without pharmacokinetic bridging studies. Confidence in clinical application remains low, and use is currently supported primarily by traditional ethnobotanical practice in Papua New Guinea and Pacific Island communities rather than controlled clinical evidence.

Nutritional Profile

Calophyllum inophyllum is not a dietary staple and does not carry meaningful macronutrient or micronutrient contributions in typical use. Its pharmacologically relevant phytochemical profile includes total phenolic content of approximately 109.16 ± 1.21 mg GAE/g dry weight and total flavonoid content of 96.88 ± 0.89 mg QE/g dry weight in leaf extracts. Leaf dry-weight phytochemical composition includes alkaloids (~11.51%), tannins (~7.68%), polyphenols (~2.53%), triterpenoids (~2.48%), flavonoids (~2.37%), and saponins (~2.16%). Key bioactive compounds — calophyllolide, inophyllum C, inophyllum P, eugenol, and caryophyllene oxide — are concentrated in the bark, seeds, and leaves; in silico analysis predicts high gastrointestinal absorption for flower-derived volatiles, but overall oral bioavailability data for the major coumarins and xanthones in humans are not established.

Preparation & Dosage

- **Seed Oil (Tamanu Oil)**: Traditionally cold-pressed from C. inophyllum seeds and applied topically to skin infections, wounds, and inflammatory lesions; no standardized dose established, but thin layers applied 1-3 times daily are common in traditional practice.
- **Bark Methanolic Extract**: Used in laboratory studies at concentrations of 0.004–18 mg/mL for antioxidant and antibacterial assays; no standardized human supplement dose has been established.
- **Leaf Extract (Ethyl Acetate or Hexane)**: Evaluated in anticancer cell studies at 10–200 μg/mL; these concentrations are research-grade benchmarks only and do not correspond to established human supplemental doses.
- **Traditional Decoction (Bark/Leaf)**: In Pacific Island and East Asian folk medicine, bark or leaf decoctions are prepared by boiling plant material in water and applied topically or used as a wash for skin infections; preparation ratios are not formally standardized.
- **Standardization Note**: No commercial supplement formulations with defined standardization percentages (e.g., % calophyllolide or % total phenolics) have been identified in the peer-reviewed literature; topical oil preparations are the most available commercial form.
- **Timing**: Topical applications are traditionally used after wound cleansing; internal preparations have not been clinically validated for timing or frequency.

Synergy & Pairings

C. inophyllum extracts may exhibit additive or synergistic antimicrobial activity when combined with quercetin, as both compounds share phenolic-mediated free radical scavenging and bacterial membrane disruption mechanisms — quercetin was used as a comparative positive control in invasion inhibition studies at 20 μg/mL alongside C. inophyllum at 200 μg/mL. Topical formulations combining tamanu oil (C. inophyllum seed oil) with other Pacific botanical oils such as coconut oil (Cocos nucifera) may enhance skin penetration through carrier lipid effects, facilitating deeper delivery of calophyllolide and xanthone constituents to infected tissue. In traditional Pacific practice, C. inophyllum preparations are often used alongside anti-inflammatory botanicals such as turmeric (Curcuma longa), potentially creating complementary inhibition of NF-κB and ROS-mediated inflammatory cascades relevant to infected wound environments.

Safety & Interactions

In vitro cytotoxicity assessments showed no cytotoxicity in normal Vero cells from methanolic extracts of flowers, leaves, twigs, and bark, but hexane and ethyl acetate extracts from leaves, twigs, and bark exhibited significant cytotoxicity against Vero cells (65.58%–92.08% cytotoxicity), indicating solvent- and plant-part-specific safety profiles that have not been characterized in human populations. No documented drug interactions, contraindications, or human adverse event data are available in the peer-reviewed literature reviewed, and comprehensive human safety pharmacology studies have not been conducted. The plant's coumarin constituents raise theoretical concerns about anticoagulant interactions if taken internally, as coumarins can potentiate warfarin and similar anticoagulants, though this has not been clinically confirmed for C. inophyllum specifically. Use during pregnancy and lactation is not recommended given the absence of safety data; maximum safe doses for internal or topical application have not been established in human studies, and use should remain conservative and monitored.